The RECOVERY Trial: design, impact, and lessons
Unfortunately Peter Horby will be unable to speak in person on Thursday.
His zoom presentation will be on display in College room 4, followed by drinks!
Please register here when you want to be present in lecture hall 4
Online you can join us with this zoom link: https://uva-live.zoom.us/j/84791662804
Host: Colin Russell
Peter Horby is a physician, epidemiologist, and Professor of Emerging Infectious Diseases and Global Health at the University of Oxford. He is the co-chief investigator of the RECOVERY Trial into drugs for COVID-19 (the largest clinical trial of COVID-19 therapeutics in the world). In June 2020, he gave a statement alongside the UK Prime Minister and UK Chief Scientific Adviser announcing the first positive trial results of the first life-saving COVID-19 drug, Dexamethasone. He is the primary author on the published preliminary report. Horby is one of the 23 attendees of the UK Scientific Advisory Group for Emergencies (SAGE) and the chair of the UK New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). He was knighted in 2021 for services to medical research.
| Start date: | |
|---|---|
| Time: | |
| End time: | |
| Max Participants: | 65 |
| Location: | Hybride meeting from Lecture room 4, location AMC |
| Webinar URL: | https://uva-live.zoom.us/j/84791662804 |
| Organisor |
Asterdam institute for Infection and Immunology- Infectious diseases program |
|---|